The pathogenesis of cryptogenic fibrosing alveolitis (CFA) involves injury, an immune/inflammatory response and fibrosis. The cause of the injury is unknown, but the identification of serum autoantibodies makes an autoimmune aetiology attractive. The core study on which this commentary is based used novel cloning and serum screening technologies in order to identify new public and private autoantibodies in sera from 12 patients with CFA. Largely negative conclusions were drawn from that study. However, we suggest that the prevalence of autoantibodies may have been underestimated, that the study was timely and that this approach is worth pursuing further
Idiopathic pulmonary fibrosis (IPF) is a progressive, usually fatal, form of interstitial lung disea...
Background: Severe acute exacerbations (AE) of idiopathic pulmonary fibrosis (IPF) are medically unt...
To clarify the clinical significance of autoantibodies to interleukin-1α (IL-1α autoantibodies) in r...
Fibrotic interstitial lung disease (fILD) has previously been associated with the presence of autoan...
Background: The clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis...
While cystic fibrosis (CF) lung disease is characterized by persistent inflammation and infections, ...
SummaryBackgroundThe clinical significance of circulating autoantibodies in idiopathic pulmonary fib...
Anti-neutrophil cytoplasmic antibodies specific for bactericidal/permeability-increasing protein (BP...
BackgroundThe clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis i...
Idiopathic Pulmonary Fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias. It...
We investigate Sarcoidosis and Idiopathic Pulmonary Fibrosis, IPF, to find markers for early fibrosi...
Background Idiopathic pulmonary fibrosis (IPF) is one of a number of interstitial lung diseases (IL...
Lung fibrosis is characterised by the accumulation of extracellular matrix within the lung and is se...
PurposeIdiopathic pulmonary fibrosis (IPF) is a restrictive fibrotic lung disease of uncertain etiol...
RATIONALE: Idiopathic Pulmonary Fibrosis (IPF) is thought to be triggered by repeated alveolar epith...
Idiopathic pulmonary fibrosis (IPF) is a progressive, usually fatal, form of interstitial lung disea...
Background: Severe acute exacerbations (AE) of idiopathic pulmonary fibrosis (IPF) are medically unt...
To clarify the clinical significance of autoantibodies to interleukin-1α (IL-1α autoantibodies) in r...
Fibrotic interstitial lung disease (fILD) has previously been associated with the presence of autoan...
Background: The clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis...
While cystic fibrosis (CF) lung disease is characterized by persistent inflammation and infections, ...
SummaryBackgroundThe clinical significance of circulating autoantibodies in idiopathic pulmonary fib...
Anti-neutrophil cytoplasmic antibodies specific for bactericidal/permeability-increasing protein (BP...
BackgroundThe clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis i...
Idiopathic Pulmonary Fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias. It...
We investigate Sarcoidosis and Idiopathic Pulmonary Fibrosis, IPF, to find markers for early fibrosi...
Background Idiopathic pulmonary fibrosis (IPF) is one of a number of interstitial lung diseases (IL...
Lung fibrosis is characterised by the accumulation of extracellular matrix within the lung and is se...
PurposeIdiopathic pulmonary fibrosis (IPF) is a restrictive fibrotic lung disease of uncertain etiol...
RATIONALE: Idiopathic Pulmonary Fibrosis (IPF) is thought to be triggered by repeated alveolar epith...
Idiopathic pulmonary fibrosis (IPF) is a progressive, usually fatal, form of interstitial lung disea...
Background: Severe acute exacerbations (AE) of idiopathic pulmonary fibrosis (IPF) are medically unt...
To clarify the clinical significance of autoantibodies to interleukin-1α (IL-1α autoantibodies) in r...